Theranostics - a sure cure for cancer after 100 years?

4Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of theranostics in oncology: exploring its history, current advances, challenges, and prospects. We present the fundamental evolution of theranostics from radiotherapeutics, cellular therapeutics, and nanotherapeutics, showcasing critical milestones in the last decade. From the early concept of targeted drug delivery to the emergence of personalized medicine, theranostics has benefited from advances in imaging technologies, molecular biology, and nanomedicine. Furthermore, we emphasize pertinent illustrations showcasing that revolutionary strategies in cancer management enhance diagnostic accuracy and provide targeted therapies customized for individual patients, thereby facilitating the implementation of personalized medicine. Finally, we describe future perspectives on current challenges, emerging topics, and advances in the field.

Cite

CITATION STYLE

APA

Song, Y., Zou, J., Castellanos, E. A., Matsuura, N., Ronald, J. A., Shuhendler, A., … Chen, X. (2024). Theranostics - a sure cure for cancer after 100 years? Theranostics. Ivyspring International Publisher. https://doi.org/10.7150/thno.96675

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free